{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T11:12:08Z","timestamp":1788606728579,"version":"build-2803163510"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,21]],"date-time":"2024-09-21T00:00:00Z","timestamp":1726876800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016078","name":"Fuzhou Science and Technology Bureau","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016078","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005270","name":"Fujian Provincial Department of Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005270","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.cca.2024.119975","type":"journal-article","created":{"date-parts":[[2024,9,21]],"date-time":"2024-09-21T01:33:48Z","timestamp":1726882428000},"page":"119975","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Diagnostic value of six plasma biomarkers in progressive supranuclear palsy, multiple system atrophy, and Parkinson\u2019s disease"],"prefix":"10.1016","volume":"565","author":[{"given":"Ying","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieming","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiming","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaochun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinyong","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.cca.2024.119975_b0005","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1097\/WCO.0b013e32823ecfa7","article-title":"Update of atypical Parkinsonian disorders","volume":"20","author":"Litvan","year":"2007","journal-title":"Curr. Opin. Neurol."},{"issue":"9","key":"10.1016\/j.cca.2024.119975_b0010","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1007\/s00415-015-7815-3","article-title":"Quality of life in patients with progressive supranuclear palsy: one-year follow-up","volume":"262","author":"Pekmezovic","year":"2015","journal-title":"J. Neurol."},{"issue":"1","key":"10.1016\/j.cca.2024.119975_b0015","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s41572-022-00382-6","article-title":"Multiple system atrophy","volume":"8","author":"Poewe","year":"2022","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"4","key":"10.1016\/j.cca.2024.119975_b0020","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1093\/brain\/awf080","article-title":"The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service","volume":"125","author":"Hughes","year":"2002","journal-title":"Brain"},{"issue":"6","key":"10.1016\/j.cca.2024.119975_b0025","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1212\/WNL.0000000000002350","article-title":"Accuracy of clinical diagnosis of Parkinson disease A systematic review and meta-analysis","volume":"86","author":"Giovanni","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.cca.2024.119975_b0030","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.parkreldis.2022.06.001","article-title":"Plasma and serum alpha-synuclein as a biomarker in Parkinson's disease: A meta-analysis","volume":"99","author":"Zubelzu","year":"2022","journal-title":"Parkinsonism Relat. Disord."},{"issue":"3","key":"10.1016\/j.cca.2024.119975_b0035","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S1474-4422(11)70014-X","article-title":"\u03b1-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study","volume":"10","author":"Mollenhauer","year":"2011","journal-title":"Lancet Neurol."},{"issue":"1","key":"10.1016\/j.cca.2024.119975_b0040","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s00401-020-02160-8","article-title":"Ultrasensitive RT-QuIC assay with high sensitivity and specificity for Lewy body-associated synucleinopathies","volume":"140","author":"Rossi","year":"2020","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.cca.2024.119975_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.exger.2022.111842","article-title":"The promise of amplification assays for accurate early detection of \u03b1-synucleinopathies: A review","volume":"165","author":"Kurapova","year":"2022","journal-title":"Exp. Gerontol."},{"issue":"12","key":"10.1016\/j.cca.2024.119975_b0050","doi-asserted-by":"crossref","first-page":"2874","DOI":"10.1002\/mds.28738","article-title":"Systematic Assessment of 10 Biomarker Candidates Focusing on \u03b1-Synuclein-Related Disorders","volume":"36","author":"Schulz","year":"2021","journal-title":"Mov. Disord."},{"key":"10.1016\/j.cca.2024.119975_b0055","doi-asserted-by":"crossref","unstructured":"S. Hall, A. \u00d6hrfelt, R. Constantinescu, et al., Accuracy of a Panel of 5 Cerebrospinal Fluid Biomarkers in the Differential Diagnosis of Patients With Dementia and\/or Parkinsonian Disorders, Arch. Neurol. 69(11) (2012). 10.1001\/archneurol.2012.1654.","DOI":"10.1001\/archneurol.2012.1654"},{"issue":"11","key":"10.1016\/j.cca.2024.119975_b0060","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1136\/jnnp-2014-309562","article-title":"A panel of nine cerebrospinal fluid biomarkers may identify patients with atypical parkinsonian syndromes","volume":"86","author":"Magdalinou","year":"2015","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.cca.2024.119975_b0065","doi-asserted-by":"crossref","unstructured":"I.M.W. Verberk, E. Thijssen, J. Koelewijn, et al., Combination of plasma amyloid beta(1-42\/1-40) and glial fibrillary acidic protein strongly associates with cerebral amyloid pathology, Alzheimers Res. Ther. 12(1) (2020). 10.1186\/s13195-020-00682-7.","DOI":"10.1186\/s13195-020-00682-7"},{"issue":"1","key":"10.1016\/j.cca.2024.119975_b0070","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S1474-4422(16)30291-5","article-title":"Neuropathological and genetic correlates of survival and dementia onset in synucleinopathies: a retrospective analysis","volume":"16","author":"Irwin","year":"2017","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.cca.2024.119975_b0075","doi-asserted-by":"crossref","unstructured":"M. Jecmenica Lukic, C. Kurz, G. Respondek, et al., Copathology in Progressive Supranuclear Palsy: Does It Matter?, Mov. Disord. 35(6) (2020) 984-993. 10.1002\/mds.28011.","DOI":"10.1002\/mds.28011"},{"issue":"10","key":"10.1016\/j.cca.2024.119975_b0080","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1212\/WNL.0000000000003680","article-title":"Blood-based NfL: A biomarker for differential diagnosis of parkinsonian disorder","volume":"88","author":"Hansson","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.cca.2024.119975_b0085","doi-asserted-by":"crossref","unstructured":"T.M. Marques, A. van Rumund, P. Oeckl, et al., Serum NFL discriminates Parkinson disease from atypical parkinsonisms, Neurology 92(13) (2019). 10.1212\/wnl.0000000000007179.","DOI":"10.1212\/WNL.0000000000007179"},{"key":"10.1016\/j.cca.2024.119975_b0090","doi-asserted-by":"crossref","unstructured":"A.S.L. Ng, Y.J. Tan, A.C.W. Yong, et al., Utility of plasma Neurofilament light as a diagnostic and prognostic biomarker of the postural instability gait disorder motor subtype in early Parkinson\u2019s disease, Mol. Neurodegener. 15(1) (2020). 10.1186\/s13024-020-00385-5.","DOI":"10.1186\/s13024-020-00385-5"},{"issue":"10","key":"10.1016\/j.cca.2024.119975_b0095","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1515\/cclm-2015-1195","article-title":"Comparison of three analytical platforms for quantification of the neurofilament light chain in blood samples: ELISA, electrochemiluminescence immunoassay and Simoa","volume":"54","author":"Kuhle","year":"2016","journal-title":"Clin. Chem. and Lab. Med. (CCLM)"},{"issue":"12","key":"10.1016\/j.cca.2024.119975_b0100","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/mds.26424","article-title":"MDS clinical diagnostic criteria for Parkinson's disease","volume":"30","author":"Postuma","year":"2015","journal-title":"Mov. Disord."},{"issue":"5","key":"10.1016\/j.cca.2024.119975_b0105","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1002\/mds.25383","article-title":"How to identify tremor dominant and postural instability\/gait difficulty groups with the movement disorder society unified Parkinson's disease rating scale: Comparison with the unified Parkinson's disease rating scale","volume":"28","author":"Stebbins","year":"2013","journal-title":"Mov. Disord."},{"issue":"9","key":"10.1016\/j.cca.2024.119975_b0110","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1212\/01.wnl.0000324625.00404.15","article-title":"Second consensus statement on the diagnosis of multiple system atrophy","volume":"71","author":"Gilman","year":"2008","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.cca.2024.119975_b0115","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1002\/mds.29005","article-title":"The Movement Disorder Society Criteria for the Diagnosis of Multiple System Atrophy","volume":"37","author":"Wenning","year":"2022","journal-title":"Mov. Disord."},{"issue":"6","key":"10.1016\/j.cca.2024.119975_b0120","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1002\/mds.26987","article-title":"Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria","volume":"32","author":"H\u00f6glinger","year":"2017","journal-title":"Mov. Disord."},{"issue":"8","key":"10.1016\/j.cca.2024.119975_b0125","first-page":"620","article-title":"Neurofilament proteins in axonal regeneration andneurodegenerative diseases","volume":"7","author":"Haitao","year":"2012","journal-title":"Neural Regen. Res."},{"issue":"1","key":"10.1016\/j.cca.2024.119975_b0130","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0006-8993(03)03219-0","article-title":"Elevated neurofilament levels in neurological diseases","volume":"987","author":"Norgren","year":"2003","journal-title":"Brain Res."},{"issue":"9","key":"10.1016\/j.cca.2024.119975_b0135","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1212\/WNL.0b013e318284070c","article-title":"Diffusion tensor imaging in parkinsonian syndromes","volume":"80","author":"Cochrane","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.cca.2024.119975_b0140","doi-asserted-by":"crossref","unstructured":"S. Baiardi, C. Quadalti, A. Mammana, et al., Diagnostic value of plasma p-tau181, NfL, and GFAP in a clinical setting cohort of prevalent neurodegenerative dementias, Alzheimers Res. Ther. 14(1) (2022). 10.1186\/s13195-022-01093-6.","DOI":"10.1186\/s13195-022-01093-6"},{"key":"10.1016\/j.cca.2024.119975_b0145","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.717930","article-title":"Detection of cerebrospinal fluid neurofilament light chain as a marker for alpha-synucleinopathies","volume":"13","author":"Canaslan","year":"2021","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.cca.2024.119975_b0150","doi-asserted-by":"crossref","unstructured":"Y. Guo, X.-N. Shen, S.-Y. Huang, et al., Head-to-head comparison of 6 plasma biomarkers in early multiple system atrophy, npj Parkinson's Disease 9(1) (2023). 10.1038\/s41531-023-00481-5.","DOI":"10.1038\/s41531-023-00481-5"},{"issue":"4","key":"10.1016\/j.cca.2024.119975_b0155","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1002\/mds.29339","article-title":"Plasma biomarkers and positron emission tomography tau pathology in progressive supranuclear palsy","volume":"38","author":"Huang","year":"2023","journal-title":"Mov. Disord."},{"issue":"2","key":"10.1016\/j.cca.2024.119975_b0160","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/PL00007711","article-title":"Immunohistochemical investigations on the course of astroglial GFAP expression following human brain injury","volume":"113","author":"Hausmann","year":"2000","journal-title":"Int. J. Legal Med."},{"key":"10.1016\/j.cca.2024.119975_b0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.108624","article-title":"Serum glial fibrillary acidic protein is a body fluid biomarker: a valuable prognostic for neurological disease \u2013 a systematic review","volume":"107","author":"Heimfarth","year":"2022","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.cca.2024.119975_b0170","article-title":"A panel of plasma biomarkers for differential diagnosis of parkinsonian syndromes","volume":"16","author":"Li","year":"2022","journal-title":"Front. Neurosci."},{"issue":"7","key":"10.1016\/j.cca.2024.119975_b0175","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1093\/brain\/awy146","article-title":"Neurodegenerative disease concomitant proteinopathies are prevalent, age-related and APOE4-associated","volume":"141","author":"Robinson","year":"2018","journal-title":"Brain"},{"issue":"8","key":"10.1016\/j.cca.2024.119975_b0180","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.1007\/s00415-020-09781-9","article-title":"Diagnostic utility of fluid biomarkers in multiple system atrophy: a systematic review and meta-analysis","volume":"268","author":"Cong","year":"2020","journal-title":"J. Neurol."},{"issue":"2","key":"10.1016\/j.cca.2024.119975_b0185","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/jnc.15944","article-title":"Cerebrospinal fluid and blood serum biomarkers in neurodegenerative proteinopathies: A prospective, open, cross-correlation study","volume":"167","author":"Kon\u00ed\u010dkov\u00e1","year":"2023","journal-title":"J. Neurochem."},{"issue":"12","key":"10.1016\/j.cca.2024.119975_b0190","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1212\/01.wnl.0000219668.47116.e6","article-title":"Neuropathology of older persons without cognitive impairment from two community-based studies","volume":"66","author":"Bennett","year":"2006","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.cca.2024.119975_b0195","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1136\/jnnp-2014-308004","article-title":"Divergent CSF \u03c4 alterations in two common tauopathies: Alzheimer\u2019s disease and progressive supranuclear palsy","volume":"86","author":"Dana","year":"2015","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"3","key":"10.1016\/j.cca.2024.119975_b0200","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/s41591-020-0755-1","article-title":"Plasma P-tau181 in Alzheimer\u2019s disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer\u2019s dementia","volume":"26","author":"Janelidze","year":"2020","journal-title":"Nat. Med."}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898124022289?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898124022289?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T05:01:16Z","timestamp":1741064476000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898124022289"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":40,"alternative-id":["S0009898124022289"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2024.119975","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnostic value of six plasma biomarkers in progressive supranuclear palsy, multiple system atrophy, and Parkinson\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2024.119975","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"119975"}}